ACCELERON PHARMA INC Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 1,500 | 5,820 | 97,251 | |
| Feb 11 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 98,751 | |
| Feb 11 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 36.65 | 1,500 | 54,975 | 25,000 | 26.5 K to 25 K (-5.66 %) |
| Feb 11 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 1,500 | 5,820 | 26,500 | 25 K to 26.5 K (+6.00 %) |
| Feb 11 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 37.11 | 400 | 14,844 | 25,000 | 25.4 K to 25 K (-1.57 %) |
| Feb 11 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 36.60 | 4,600 | 168,360 | 25,400 | 30 K to 25.4 K (-15.33 %) |
| Feb 11 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 30,000 | 25 K to 30 K (+20.00 %) |
| Feb 11 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 37.20 | 1,937 | 72,056 | 47,584 | 49.5 K to 47.6 K (-3.91 %) |
| Feb 11 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 36.59 | 18,063 | 660,925 | 49,521 | 67.6 K to 49.5 K (-26.73 %) |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 1.80 | 5,000 | 9,000 | 1,094 | |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 39.95 | 300 | 11,985 | 52,656 | 53 K to 52.7 K (-0.57 %) |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 39.03 | 1,900 | 74,157 | 52,956 | 54.9 K to 53 K (-3.46 %) |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 38.33 | 2,800 | 107,324 | 54,856 | 57.7 K to 54.9 K (-4.86 %) |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 1.80 | 5,000 | 9,000 | 57,656 | 52.7 K to 57.7 K (+9.50 %) |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Option Exercise | M | 5.88 | 4,000 | 23,520 | 500 | |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 39.46 | 300 | 11,838 | 34,700 | 35 K to 34.7 K (-0.86 %) |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 38.56 | 1,200 | 46,272 | 35,000 | 36.2 K to 35 K (-3.31 %) |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 39.13 | 1,435 | 56,152 | 36,200 | 37.6 K to 36.2 K (-3.81 %) |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 38.39 | 2,565 | 98,470 | 37,635 | 40.2 K to 37.6 K (-6.38 %) |
| Feb 04 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Buy | M | 5.88 | 4,000 | 23,520 | 40,200 | 36.2 K to 40.2 K (+11.05 %) |